Product news

Share this article:

Xanodyne Pharmaceuticals has received an approvable letter from the FDA for Zipsor, indicated for mild to moderate acute pain. Zipsor is an immediate release liquid-filled soft gelatin capsule containing 25 mg of diclofenac potassium, for oral administration.   

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Janssen recruits Debbie Allen for T2 Diabetes

Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.

Pfizer seeks wider Xeljanz indication

The company expects to file an sNDA for plaque psoriasis next year.

Recalls dent Stryker Q1 earnings

Sales rose 5% compared to the same period last year.